[go: up one dir, main page]

DE60235809D1 - Nukleinsäurefreie ghost zusammensetzungen - Google Patents

Nukleinsäurefreie ghost zusammensetzungen

Info

Publication number
DE60235809D1
DE60235809D1 DE60235809T DE60235809T DE60235809D1 DE 60235809 D1 DE60235809 D1 DE 60235809D1 DE 60235809 T DE60235809 T DE 60235809T DE 60235809 T DE60235809 T DE 60235809T DE 60235809 D1 DE60235809 D1 DE 60235809D1
Authority
DE
Germany
Prior art keywords
compositions
nucleic acid
free ghost
ghost
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235809T
Other languages
English (en)
Inventor
Werner Lubitz
Wolfgang Haidinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60235809D1 publication Critical patent/DE60235809D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60235809T 2001-07-11 2002-07-11 Nukleinsäurefreie ghost zusammensetzungen Expired - Lifetime DE60235809D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30459501P 2001-07-11 2001-07-11
PCT/EP2002/007758 WO2003006630A2 (en) 2001-07-11 2002-07-11 Nucleic acid free ghost preparations

Publications (1)

Publication Number Publication Date
DE60235809D1 true DE60235809D1 (de) 2010-05-12

Family

ID=23177160

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235809T Expired - Lifetime DE60235809D1 (de) 2001-07-11 2002-07-11 Nukleinsäurefreie ghost zusammensetzungen

Country Status (8)

Country Link
US (1) US7399476B2 (de)
EP (1) EP1404808B1 (de)
AT (1) ATE462779T1 (de)
AU (1) AU2002328340B2 (de)
CA (1) CA2453518C (de)
DE (1) DE60235809D1 (de)
NZ (1) NZ530780A (de)
WO (1) WO2003006630A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614471D0 (en) 2006-07-20 2006-08-30 Syngenta Ltd Herbicidal Compounds
WO2009090093A1 (en) * 2008-01-18 2009-07-23 Werner Lubitz Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
IN2012DN03418A (de) 2009-10-09 2015-10-23 Childrens Medical Center
PL2591798T3 (pl) 2011-11-09 2015-04-30 Werner Lubitz Szczepionka do zastosowania w immunoterapii nowotworów
EP3195878A1 (de) 2016-01-22 2017-07-26 Werner Lubitz Bakterielle ghosts zur behandlung von krebs
JP7376208B2 (ja) 2017-10-25 2023-11-08 アレーロ セラピューティクス ビーヴイ 抗原特異的製剤の投与による免疫疾患の治療
CN112410360A (zh) * 2021-01-18 2021-02-26 西南大学 一种鸡病原细菌菌影及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177083B1 (en) * 1990-07-26 2001-01-23 Evax Technologies Gmbh Process for the production of vaccines and their use
NZ274482A (en) * 1993-10-13 1997-09-22 Gx Biosystems As Cells transformed with a truncated and/or mutated staphylococcus aureus nuclease and their use in immunological, pesticidal and environmental pollutant-degrading compositions

Also Published As

Publication number Publication date
WO2003006630A3 (en) 2003-10-23
AU2002328340B2 (en) 2007-06-28
CA2453518C (en) 2010-02-02
ATE462779T1 (de) 2010-04-15
US7399476B2 (en) 2008-07-15
WO2003006630A2 (en) 2003-01-23
CA2453518A1 (en) 2003-01-23
EP1404808B1 (de) 2010-03-31
NZ530780A (en) 2005-06-24
EP1404808A2 (de) 2004-04-07
US20040213810A1 (en) 2004-10-28

Similar Documents

Publication Publication Date Title
CY1119742T1 (el) Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
BR0010721A (pt) Composições de neisserias combinadas
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
DK1458760T3 (da) Indfangede bindingsproteiner som biosensorer
BG101103A (bg) Теломераза при бозайници
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
EP2322203A3 (de) Gestaltungen und methoden für die behandlung von Immune verwandte Krankheiten
IL217317A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same and uses thereof
BR0207394A (pt) Proteìna de fusão para a secreção de uma proteìna de interesse no sobrenadante da cultura bacteriana
WO2002024883A3 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
WO2008052173A8 (en) Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
ATE418070T1 (de) Dekodierung von matrixsensoren mit mikrokugeln
SI1622939T1 (sl) Akrivne variante il-18 vezavnega proteina in medicinske uporabe le-tega
ATE314084T1 (de) Kahalalid f formulierung
EP1572084A4 (de) Säugetiergene mit beteiligung an virusinfektion und tumorsuppression
ATE462779T1 (de) Nukleinsäurefreie ghost zusammensetzungen
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
BRPI0407176A (pt) Cepas de bifidobacterium possuindo a capacidade de produzir glutamina
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
EP2116616A3 (de) In aktivierten T-Zellen differentiell exprimierte Gene und deren Verwendungen
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
IT1317905B1 (it) Varianti di allergeni ns-ltps, loro usi e composizioni che lecomprendono.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition